nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Gadoxetate—ABCC3—hematologic cancer	0.00728	0.513	CrCbGaD
Gadodiamide—Gadobenate Dimeglumine—ALB—hematologic cancer	0.00345	0.243	CrCbGaD
Gadodiamide—Gadofosveset trisodium—ALB—hematologic cancer	0.00345	0.243	CrCbGaD
Gadodiamide—Visual impairment—Epirubicin—hematologic cancer	0.000174	0.000177	CcSEcCtD
Gadodiamide—Rash—Irinotecan—hematologic cancer	0.000174	0.000176	CcSEcCtD
Gadodiamide—Rash—Mitoxantrone—hematologic cancer	0.000174	0.000176	CcSEcCtD
Gadodiamide—Dermatitis—Mitoxantrone—hematologic cancer	0.000174	0.000176	CcSEcCtD
Gadodiamide—Dermatitis—Irinotecan—hematologic cancer	0.000174	0.000176	CcSEcCtD
Gadodiamide—Chills—Methotrexate—hematologic cancer	0.000174	0.000176	CcSEcCtD
Gadodiamide—Headache—Mitoxantrone—hematologic cancer	0.000173	0.000175	CcSEcCtD
Gadodiamide—Headache—Irinotecan—hematologic cancer	0.000173	0.000175	CcSEcCtD
Gadodiamide—Nausea—Ifosfamide—hematologic cancer	0.000173	0.000175	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000172	0.000174	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000172	0.000174	CcSEcCtD
Gadodiamide—Myalgia—Prednisone—hematologic cancer	0.000172	0.000174	CcSEcCtD
Gadodiamide—Arthralgia—Prednisone—hematologic cancer	0.000172	0.000174	CcSEcCtD
Gadodiamide—Feeling abnormal—Triamcinolone—hematologic cancer	0.000171	0.000174	CcSEcCtD
Gadodiamide—Diarrhoea—Cisplatin—hematologic cancer	0.000171	0.000174	CcSEcCtD
Gadodiamide—Anxiety—Prednisone—hematologic cancer	0.000171	0.000173	CcSEcCtD
Gadodiamide—Vomiting—Gemcitabine—hematologic cancer	0.000171	0.000173	CcSEcCtD
Gadodiamide—Paraesthesia—Dexamethasone—hematologic cancer	0.00017	0.000172	CcSEcCtD
Gadodiamide—Paraesthesia—Betamethasone—hematologic cancer	0.00017	0.000172	CcSEcCtD
Gadodiamide—Discomfort—Prednisone—hematologic cancer	0.000169	0.000172	CcSEcCtD
Gadodiamide—Rash—Gemcitabine—hematologic cancer	0.000169	0.000172	CcSEcCtD
Gadodiamide—Dermatitis—Gemcitabine—hematologic cancer	0.000169	0.000172	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—hematologic cancer	0.000169	0.000171	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—hematologic cancer	0.000169	0.000171	CcSEcCtD
Gadodiamide—Headache—Gemcitabine—hematologic cancer	0.000168	0.000171	CcSEcCtD
Gadodiamide—Nausea—Vincristine—hematologic cancer	0.000168	0.000171	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—hematologic cancer	0.000168	0.00017	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—hematologic cancer	0.000168	0.00017	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisolone—hematologic cancer	0.000167	0.000169	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—hematologic cancer	0.000166	0.000169	CcSEcCtD
Gadodiamide—Dyspepsia—Betamethasone—hematologic cancer	0.000166	0.000169	CcSEcCtD
Gadodiamide—Dyspepsia—Dexamethasone—hematologic cancer	0.000166	0.000169	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—hematologic cancer	0.000165	0.000168	CcSEcCtD
Gadodiamide—Urticaria—Triamcinolone—hematologic cancer	0.000165	0.000168	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—hematologic cancer	0.000165	0.000167	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—hematologic cancer	0.000165	0.000167	CcSEcCtD
Gadodiamide—Body temperature increased—Triamcinolone—hematologic cancer	0.000164	0.000167	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisone—hematologic cancer	0.000164	0.000167	CcSEcCtD
Gadodiamide—Oedema—Prednisone—hematologic cancer	0.000164	0.000167	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—hematologic cancer	0.000164	0.000167	CcSEcCtD
Gadodiamide—Nausea—Mitoxantrone—hematologic cancer	0.000164	0.000166	CcSEcCtD
Gadodiamide—Nausea—Irinotecan—hematologic cancer	0.000164	0.000166	CcSEcCtD
Gadodiamide—Infection—Prednisone—hematologic cancer	0.000163	0.000166	CcSEcCtD
Gadodiamide—Fatigue—Betamethasone—hematologic cancer	0.000163	0.000165	CcSEcCtD
Gadodiamide—Fatigue—Dexamethasone—hematologic cancer	0.000163	0.000165	CcSEcCtD
Gadodiamide—Chills—Epirubicin—hematologic cancer	0.000162	0.000165	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—hematologic cancer	0.000162	0.000165	CcSEcCtD
Gadodiamide—Shock—Prednisone—hematologic cancer	0.000162	0.000164	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—hematologic cancer	0.000162	0.000164	CcSEcCtD
Gadodiamide—Pain—Dexamethasone—hematologic cancer	0.000161	0.000164	CcSEcCtD
Gadodiamide—Pain—Betamethasone—hematologic cancer	0.000161	0.000164	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—hematologic cancer	0.000161	0.000164	CcSEcCtD
Gadodiamide—Nervous system disorder—Prednisone—hematologic cancer	0.000161	0.000164	CcSEcCtD
Gadodiamide—Tachycardia—Prednisone—hematologic cancer	0.00016	0.000163	CcSEcCtD
Gadodiamide—Nausea—Gemcitabine—hematologic cancer	0.00016	0.000162	CcSEcCtD
Gadodiamide—Vomiting—Cisplatin—hematologic cancer	0.000159	0.000161	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisone—hematologic cancer	0.000159	0.000161	CcSEcCtD
Gadodiamide—Rash—Cisplatin—hematologic cancer	0.000158	0.00016	CcSEcCtD
Gadodiamide—Dermatitis—Cisplatin—hematologic cancer	0.000158	0.00016	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—hematologic cancer	0.000157	0.000159	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—hematologic cancer	0.000156	0.000158	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—hematologic cancer	0.000156	0.000158	CcSEcCtD
Gadodiamide—Feeling abnormal—Dexamethasone—hematologic cancer	0.000156	0.000158	CcSEcCtD
Gadodiamide—Feeling abnormal—Betamethasone—hematologic cancer	0.000156	0.000158	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—hematologic cancer	0.000155	0.000158	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000154	0.000157	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000154	0.000157	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—hematologic cancer	0.000154	0.000157	CcSEcCtD
Gadodiamide—Hypersensitivity—Triamcinolone—hematologic cancer	0.000153	0.000155	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—hematologic cancer	0.000152	0.000154	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—hematologic cancer	0.000152	0.000154	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—hematologic cancer	0.00015	0.000152	CcSEcCtD
Gadodiamide—Urticaria—Betamethasone—hematologic cancer	0.00015	0.000152	CcSEcCtD
Gadodiamide—Urticaria—Dexamethasone—hematologic cancer	0.00015	0.000152	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.00015	0.000152	CcSEcCtD
Gadodiamide—Dizziness—Prednisolone—hematologic cancer	0.00015	0.000152	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—hematologic cancer	0.00015	0.000152	CcSEcCtD
Gadodiamide—Asthenia—Triamcinolone—hematologic cancer	0.000149	0.000151	CcSEcCtD
Gadodiamide—Abdominal pain—Dexamethasone—hematologic cancer	0.000149	0.000151	CcSEcCtD
Gadodiamide—Abdominal pain—Betamethasone—hematologic cancer	0.000149	0.000151	CcSEcCtD
Gadodiamide—Body temperature increased—Betamethasone—hematologic cancer	0.000149	0.000151	CcSEcCtD
Gadodiamide—Body temperature increased—Dexamethasone—hematologic cancer	0.000149	0.000151	CcSEcCtD
Gadodiamide—Nausea—Cisplatin—hematologic cancer	0.000149	0.000151	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisone—hematologic cancer	0.000148	0.00015	CcSEcCtD
Gadodiamide—Pruritus—Triamcinolone—hematologic cancer	0.000147	0.000149	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—hematologic cancer	0.000146	0.000148	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—hematologic cancer	0.000146	0.000148	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—hematologic cancer	0.000146	0.000148	CcSEcCtD
Gadodiamide—Dyspepsia—Prednisone—hematologic cancer	0.000145	0.000147	CcSEcCtD
Gadodiamide—Rash—Etoposide—hematologic cancer	0.000145	0.000147	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—hematologic cancer	0.000144	0.000147	CcSEcCtD
Gadodiamide—Headache—Etoposide—hematologic cancer	0.000144	0.000146	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—hematologic cancer	0.000143	0.000145	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—hematologic cancer	0.000143	0.000145	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—hematologic cancer	0.000143	0.000145	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—hematologic cancer	0.000143	0.000145	CcSEcCtD
Gadodiamide—Rash—Prednisolone—hematologic cancer	0.000143	0.000145	CcSEcCtD
Gadodiamide—Dermatitis—Prednisolone—hematologic cancer	0.000143	0.000145	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—hematologic cancer	0.000142	0.000144	CcSEcCtD
Gadodiamide—Fatigue—Prednisone—hematologic cancer	0.000142	0.000144	CcSEcCtD
Gadodiamide—Headache—Prednisolone—hematologic cancer	0.000142	0.000144	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—hematologic cancer	0.000142	0.000144	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—hematologic cancer	0.000141	0.000143	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—hematologic cancer	0.000138	0.00014	CcSEcCtD
Gadodiamide—Dizziness—Triamcinolone—hematologic cancer	0.000138	0.00014	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—hematologic cancer	0.000137	0.000139	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—hematologic cancer	0.000137	0.000138	CcSEcCtD
Gadodiamide—Infection—Methotrexate—hematologic cancer	0.000137	0.000138	CcSEcCtD
Gadodiamide—Nausea—Etoposide—hematologic cancer	0.000136	0.000138	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisone—hematologic cancer	0.000135	0.000137	CcSEcCtD
Gadodiamide—Asthenia—Betamethasone—hematologic cancer	0.000135	0.000137	CcSEcCtD
Gadodiamide—Asthenia—Dexamethasone—hematologic cancer	0.000135	0.000137	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—hematologic cancer	0.000135	0.000137	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—hematologic cancer	0.000135	0.000137	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Prednisone—hematologic cancer	0.000134	0.000136	CcSEcCtD
Gadodiamide—Nausea—Prednisolone—hematologic cancer	0.000134	0.000136	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—hematologic cancer	0.000134	0.000136	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—hematologic cancer	0.000134	0.000136	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—hematologic cancer	0.000134	0.000136	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—hematologic cancer	0.000134	0.000136	CcSEcCtD
Gadodiamide—Pruritus—Dexamethasone—hematologic cancer	0.000134	0.000135	CcSEcCtD
Gadodiamide—Pruritus—Betamethasone—hematologic cancer	0.000134	0.000135	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—hematologic cancer	0.000133	0.000135	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—hematologic cancer	0.000133	0.000134	CcSEcCtD
Gadodiamide—Vomiting—Triamcinolone—hematologic cancer	0.000132	0.000134	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—hematologic cancer	0.000131	0.000133	CcSEcCtD
Gadodiamide—Rash—Triamcinolone—hematologic cancer	0.000131	0.000133	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—hematologic cancer	0.000131	0.000133	CcSEcCtD
Gadodiamide—Dermatitis—Triamcinolone—hematologic cancer	0.000131	0.000133	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—hematologic cancer	0.000131	0.000133	CcSEcCtD
Gadodiamide—Urticaria—Prednisone—hematologic cancer	0.000131	0.000132	CcSEcCtD
Gadodiamide—Headache—Triamcinolone—hematologic cancer	0.00013	0.000132	CcSEcCtD
Gadodiamide—Abdominal pain—Prednisone—hematologic cancer	0.00013	0.000132	CcSEcCtD
Gadodiamide—Body temperature increased—Prednisone—hematologic cancer	0.00013	0.000132	CcSEcCtD
Gadodiamide—Diarrhoea—Dexamethasone—hematologic cancer	0.000129	0.000131	CcSEcCtD
Gadodiamide—Diarrhoea—Betamethasone—hematologic cancer	0.000129	0.000131	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—hematologic cancer	0.000129	0.00013	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—hematologic cancer	0.000129	0.00013	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—hematologic cancer	0.000128	0.00013	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—hematologic cancer	0.000128	0.00013	CcSEcCtD
Gadodiamide—Infection—Epirubicin—hematologic cancer	0.000128	0.00013	CcSEcCtD
Gadodiamide—Shock—Epirubicin—hematologic cancer	0.000127	0.000128	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—hematologic cancer	0.000126	0.000128	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—hematologic cancer	0.000126	0.000128	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—hematologic cancer	0.000125	0.000127	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000125	0.000127	CcSEcCtD
Gadodiamide—Dizziness—Dexamethasone—hematologic cancer	0.000125	0.000127	CcSEcCtD
Gadodiamide—Dizziness—Betamethasone—hematologic cancer	0.000125	0.000127	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—hematologic cancer	0.000124	0.000126	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—hematologic cancer	0.000124	0.000126	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—hematologic cancer	0.000124	0.000126	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—hematologic cancer	0.000124	0.000126	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—hematologic cancer	0.000124	0.000125	CcSEcCtD
Gadodiamide—Nausea—Triamcinolone—hematologic cancer	0.000124	0.000125	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—hematologic cancer	0.000123	0.000125	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—hematologic cancer	0.000123	0.000124	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—hematologic cancer	0.000122	0.000124	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—hematologic cancer	0.000122	0.000124	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—hematologic cancer	0.000121	0.000123	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisone—hematologic cancer	0.000121	0.000123	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—hematologic cancer	0.000121	0.000123	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—hematologic cancer	0.00012	0.000122	CcSEcCtD
Gadodiamide—Vomiting—Dexamethasone—hematologic cancer	0.00012	0.000122	CcSEcCtD
Gadodiamide—Vomiting—Betamethasone—hematologic cancer	0.00012	0.000122	CcSEcCtD
Gadodiamide—Rash—Betamethasone—hematologic cancer	0.000119	0.000121	CcSEcCtD
Gadodiamide—Rash—Dexamethasone—hematologic cancer	0.000119	0.000121	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—hematologic cancer	0.000119	0.000121	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000119	0.000121	CcSEcCtD
Gadodiamide—Dermatitis—Dexamethasone—hematologic cancer	0.000119	0.000121	CcSEcCtD
Gadodiamide—Dermatitis—Betamethasone—hematologic cancer	0.000119	0.000121	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—hematologic cancer	0.000118	0.00012	CcSEcCtD
Gadodiamide—Headache—Betamethasone—hematologic cancer	0.000118	0.00012	CcSEcCtD
Gadodiamide—Headache—Dexamethasone—hematologic cancer	0.000118	0.00012	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—hematologic cancer	0.000118	0.00012	CcSEcCtD
Gadodiamide—Asthenia—Prednisone—hematologic cancer	0.000118	0.00012	CcSEcCtD
Gadodiamide—Pain—Methotrexate—hematologic cancer	0.000117	0.000119	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000117	0.000119	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—hematologic cancer	0.000117	0.000119	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—hematologic cancer	0.000117	0.000118	CcSEcCtD
Gadodiamide—Pruritus—Prednisone—hematologic cancer	0.000116	0.000118	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—hematologic cancer	0.000116	0.000118	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—hematologic cancer	0.000115	0.000117	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000115	0.000117	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—hematologic cancer	0.000115	0.000116	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—hematologic cancer	0.000114	0.000116	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—hematologic cancer	0.000113	0.000115	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—hematologic cancer	0.000113	0.000115	CcSEcCtD
Gadodiamide—Diarrhoea—Prednisone—hematologic cancer	0.000112	0.000114	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000112	0.000114	CcSEcCtD
Gadodiamide—Nausea—Dexamethasone—hematologic cancer	0.000112	0.000114	CcSEcCtD
Gadodiamide—Nausea—Betamethasone—hematologic cancer	0.000112	0.000114	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—hematologic cancer	0.000111	0.000113	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—hematologic cancer	0.000111	0.000112	CcSEcCtD
Gadodiamide—Pain—Epirubicin—hematologic cancer	0.00011	0.000112	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—hematologic cancer	0.000109	0.000111	CcSEcCtD
Gadodiamide—Dizziness—Prednisone—hematologic cancer	0.000109	0.00011	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—hematologic cancer	0.000109	0.00011	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—hematologic cancer	0.000109	0.00011	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000108	0.00011	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—hematologic cancer	0.000107	0.000108	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—hematologic cancer	0.000106	0.000107	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—hematologic cancer	0.000106	0.000107	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—hematologic cancer	0.000105	0.000106	CcSEcCtD
Gadodiamide—Vomiting—Prednisone—hematologic cancer	0.000105	0.000106	CcSEcCtD
Gadodiamide—Rash—Prednisone—hematologic cancer	0.000104	0.000105	CcSEcCtD
Gadodiamide—Dermatitis—Prednisone—hematologic cancer	0.000104	0.000105	CcSEcCtD
Gadodiamide—Headache—Prednisone—hematologic cancer	0.000103	0.000104	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—hematologic cancer	0.000103	0.000104	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—hematologic cancer	0.000102	0.000104	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—hematologic cancer	0.000102	0.000103	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—hematologic cancer	0.000102	0.000103	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—hematologic cancer	0.000102	0.000103	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—hematologic cancer	0.000101	0.000103	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—hematologic cancer	9.86e-05	0.0001	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—hematologic cancer	9.8e-05	9.95e-05	CcSEcCtD
Gadodiamide—Nausea—Prednisone—hematologic cancer	9.77e-05	9.91e-05	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.73e-05	9.87e-05	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—hematologic cancer	9.72e-05	9.86e-05	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—hematologic cancer	9.47e-05	9.61e-05	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—hematologic cancer	9.45e-05	9.59e-05	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—hematologic cancer	9.41e-05	9.54e-05	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—hematologic cancer	9.41e-05	9.54e-05	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—hematologic cancer	9.4e-05	9.54e-05	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—hematologic cancer	9.23e-05	9.36e-05	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—hematologic cancer	9.1e-05	9.23e-05	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—hematologic cancer	9.09e-05	9.22e-05	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—hematologic cancer	8.8e-05	8.92e-05	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—hematologic cancer	8.77e-05	8.89e-05	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—hematologic cancer	8.74e-05	8.86e-05	CcSEcCtD
Gadodiamide—Rash—Methotrexate—hematologic cancer	8.66e-05	8.79e-05	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—hematologic cancer	8.66e-05	8.78e-05	CcSEcCtD
Gadodiamide—Headache—Methotrexate—hematologic cancer	8.61e-05	8.73e-05	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—hematologic cancer	8.54e-05	8.66e-05	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—hematologic cancer	8.5e-05	8.63e-05	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—hematologic cancer	8.42e-05	8.54e-05	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—hematologic cancer	8.18e-05	8.29e-05	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—hematologic cancer	8.16e-05	8.28e-05	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—hematologic cancer	8.14e-05	8.26e-05	CcSEcCtD
Gadodiamide—Rash—Epirubicin—hematologic cancer	8.11e-05	8.22e-05	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—hematologic cancer	8.1e-05	8.22e-05	CcSEcCtD
Gadodiamide—Headache—Epirubicin—hematologic cancer	8.06e-05	8.17e-05	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—hematologic cancer	7.87e-05	7.98e-05	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—hematologic cancer	7.64e-05	7.75e-05	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—hematologic cancer	7.56e-05	7.67e-05	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—hematologic cancer	7.5e-05	7.61e-05	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—hematologic cancer	7.49e-05	7.6e-05	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—hematologic cancer	7.45e-05	7.56e-05	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—hematologic cancer	7.07e-05	7.17e-05	CcSEcCtD
